ISOLATION OF AN IMMUNOSUPPRESSIVE METABOLITE OF FK506 GENERATED BY HUMAN MICROSOME PREPARATIONS

被引：31

作者：

CHRISTIANS, U

RADEKE, HH

KOWNATZKI, R

SCHIEBEL, HM

SCHOTTMANN, R

SEWING, KF

机构：

[1] MED HSCH HANNOVER,INST ALLGEMEINE PHARMAKOL,KONSTANTY GUTSCHOW STR 8,W-3000 HANNOVER 61,GERMANY

[2] HANOVER MED SCH,INST MOLEK PHARMAKOL,W-3000 HANNOVER 61,GERMANY

[3] HANOVER MED SCH,ZENTRUM BIOCHEM,W-3000 HANNOVER 61,GERMANY

[4] TECH UNIV BRAUNSCHWEIG,INST ORGAN CHEM,W-3300 BRAUNSCHWEIG,GERMANY

来源：

CLINICAL BIOCHEMISTRY | 1991年 / 24卷 / 03期

关键词：

FK506; BIOTRANSFORMATION; IMMUNOSUPPRESSIVE AGENTS;

D O I：

10.1016/0009-9120(91)80019-Y

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Metabolism of FK506, a 23 member macrolide under clinical investigation as immunosuppressant after transplantation, was studied using human liver microsomes. Two fractions isolated by semi-preparative HPLC were identified by negative fast atom bombardment mass spectrometry as FK506 metabolites with mass peaks at m/z = 790 indicating demethylation of the mother compound. The immunosuppressive activity of one metabolite was evaluated in a ConA-stimulated peripheral rat lymphocyte assay. FK506 had an IC50 of 0.186 nmol/L and the metabolite tested of 1.89 nmol/L.

引用

页码：271 / 275

页数：5

共 7 条

[1] GOTO T, 1987, TRANSPLANT P, V19, P4
[2] Guengerich FP, 1982, PRINCIPLES METHODS T, P609
[3] KINO T, 1987, TRANSPLANT P, V19, P36
[4] STARZL TE, 1989, LANCET, V2, P1000
[5] TANAKA H, 1987, TRANSPLANT P, V19, P11
[6] STRUCTURE OF FK506 - A NOVEL IMMUNOSUPPRESSANT ISOLATED FROM STREPTOMYCES
TANAKA, H
KURODA, A
MARUSAWA, H
HATANAKA, H
KINO, T
GOTO, T
HASHIMOTO, M
TAGA, T
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1987, 109 (16) : 5031 - 5033
[7] VENKATARAMANAN R, 1987, TRANSPLANT P, V19, P30

← 1 →